<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05099432</url>
  </required_header>
  <id_info>
    <org_study_id>75076</org_study_id>
    <nct_id>NCT05099432</nct_id>
  </id_info>
  <brief_title>The CARMA Technique Study</brief_title>
  <official_title>The Cap-Assisted Resection Margin Assessment (CARMA) Technique After Polyp Resection: a Prospective Feasibility Study of a &quot;Novel&quot; Approach to Reduce Polyp Recurrence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Princess Alexandra Hospital, Brisbane, Australia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Princess Alexandra Hospital, Brisbane, Australia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colonoscopic removal of polyps is an important and well-established tool in the prevention of&#xD;
      colorectal cancers. However, high polyp recurrence rates after endoscopic resection, with&#xD;
      resultant development of interval cancers, remains a problemÍ¾ this most commonly stems from&#xD;
      unrecognised incomplete polyp resection. Thus, a standardised endoscopic technique is needed&#xD;
      that will allow endoscopists to consistently achieve a clear margin of resection. The&#xD;
      investigators believe the Cap Assisted Resection Margin Assessment (CARMA) technique will&#xD;
      address this problem. This novel technique focuses on a standardised assessment of the&#xD;
      resection margin after endoscopic polypectomy utilising available standard high-definition&#xD;
      video endoscopes with imaging features including narrow band imaging (NBI) and magnification&#xD;
      endoscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2026</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of achieving a clear resection margin using the CARMA technique</measure>
    <time_frame>Established during index procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of the CARMA technique for residual polyp detection</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of residual polyp without CARMA assessment</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incomplete resection rate with use of CARMA technique</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incomplete resection rate with use of the CARMA technique in polyps &gt; 10mm with hot snare</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incomplete resection rate with use of the CARMA technique in polyps &gt; 10mm with cold snare</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual polyp rate after CARMA technique with hot snare</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual polyp rate after CARMA technique with cold snare</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time required for application of the CARMA technique with &lt; 10mm</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time required for application of the CARMA technique with &gt; 10mm</measure>
    <time_frame>Established during index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyp recurrence rate for &lt; 10mm polyps</measure>
    <time_frame>Established during surveillance procedure (following national guidelines - between 6 months to 5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyp recurrence rate for &gt; 10mm polyps</measure>
    <time_frame>Established during surveillance procedure (following national guidelines - between 6 months to 5 years)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Colonic Polyp</condition>
  <condition>Colonic Sessile Serrated Lesion</condition>
  <arm_group>
    <arm_group_label>CARMA Technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All included participants undergo polyp resection using standard of care polypectomy techniques, followed by the CARMA technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CARMA technique</intervention_name>
    <description>Once standard polyp resection and assessment of the polypectomy site without magnification is completed, the CARMA technique will be applied. This will involve an assessment of the entire polypectomy margin using cap assisted magnification endoscopy with the ability to also use NBI (at the endoscopist's discretion) and documentation of any residual polyp noted.</description>
    <arm_group_label>CARMA Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients with colonic polyps will be considered following below criteria&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
        - any polypectomy (though only a maximum of two polyps from one individual participant)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  polyps less than 10mm which were resected under endoscopic view with a definite &gt; 1mm&#xD;
             clear margin&#xD;
&#xD;
          -  scar site recurrence polyps&#xD;
&#xD;
          -  polyps with endoscopic evidence of invasion&#xD;
&#xD;
          -  pedunculated polyps&#xD;
&#xD;
          -  pseudopolyps&#xD;
&#xD;
          -  participants who will not be available for follow up endoscopy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Huelsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Princess Alexandra Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Huelsen, MD</last_name>
    <phone>+61 7 3176 2111</phone>
    <email>alexander.huelsenkatz@health.qld.gov.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Huelsen, MD</last_name>
      <phone>+61 7 3176 2111</phone>
      <email>alexander.huelsenkatz@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Alexander Huelsen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zaki Hamarneh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prabha Selvanathan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Borowsky</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline Cooper</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Princess Alexandra Hospital, Brisbane, Australia</investigator_affiliation>
    <investigator_full_name>Alexander Huelsen</investigator_full_name>
    <investigator_title>Interventional Gastroenterologist, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyps</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 14, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT05099432/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 14, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT05099432/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

